Literature DB >> 23981610

Health related quality of life among patients with chronic graft-versus-host disease in China.

Xiao-dong Mo1, Lan-ping Xu, Dai-hong Liu, Yu-hong Chen, Xiao-hui Zhang, Huan Chen, Wei Han, Yu Wang, Feng-rong Wang, Jing-zhi Wang, Kai-yan Liu, Xiao-jun Huang.   

Abstract

BACKGROUND: Chronic graft-versus-host disease (GVHD), the commonest long-term complication after allogeneic hematopoietic stem cell transplantation (HSCT), has a negative impact on patients' health related quality of life (HRQoL). This study was designed to investigate the HRQoL in patients with chronic GVHD in China.
METHODS: Two hundred and sixty-four patients with chronic GVHD who were ≥ 24 months post-HSCT and had been in continuous complete remission since HSCT were enrolled in this retrospective study. HRQoL was evaluated using an SF-36 questionnaire. Multivariate analysis was used to identify the factors that affect HRQoL in patients with chronic GVHD.
RESULTS: HRQoL in patients categorized as having mild and moderate chronic GVHD was significantly better than in those in the severe category. In the moderate chronic GVHD category, markedly poorer HRQoL was observed in patients with both multiple organ involvement and more severe organ impairment than in those without these factors. According to multivariate analysis, chronic GVHD severity had the greatest significant negative impact on patients' HRQoL; whereas being female was associated with a negative impact on psychological health.
CONCLUSION: Chronic GVHD severity strongly correlates with negative impacts on patients' HRQoL.

Entities:  

Mesh:

Year:  2013        PMID: 23981610

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  8 in total

1.  Symptom distress predicts long-term health and well-being in allogeneic stem cell transplantation survivors.

Authors:  Margaret F Bevans; Sandra A Mitchell; John A Barrett; Michael R Bishop; Richard Childs; Daniel Fowler; Michael Krumlauf; Patricia Prince; Nonniekaye Shelburne; Leslie Wehrlen; Li Yang
Journal:  Biol Blood Marrow Transplant       Date:  2013-12-17       Impact factor: 5.742

2.  Chronic GVHD induced GVL effect after unmanipulated haploidentical hematopoietic SCT for AML and myelodysplastic syndrome.

Authors:  X-D Mo; L-P Xu; X-H Zhang; D-H Liu; Y Wang; H Chen; C-H Yan; Y-H Chen; W Han; F-R Wang; J-Z Wang; K-Y Liu; X-J Huang
Journal:  Bone Marrow Transplant       Date:  2014-11-10       Impact factor: 5.483

3.  Haploidentical hematopoietic stem cell transplantation without in vitro T-cell-depletion for the treatment of hematologic diseases.

Authors:  Xiao-Jun Huang
Journal:  Chimerism       Date:  2013-01-01

Review 4.  Physical function and quality of life in patients with chronic GvHD: a summary of preclinical and clinical studies and a call for exercise intervention trials in patients.

Authors:  C Fiuza-Luces; R J Simpson; M Ramírez; A Lucia; N A Berger
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483

5.  Preemptive Immunotherapy for Minimal Residual Disease in Patients With t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Shuang Fan; Meng-Zhu Shen; Xiao-Hui Zhang; Lan-Ping Xu; Yu Wang; Chen-Hua Yan; Huan Chen; Yu-Hong Chen; Wei Han; Feng-Rong Wang; Jing-Zhi Wang; Xiao-Su Zhao; Ya-Zhen Qin; Ying-Jun Chang; Kai-Yan Liu; Xiao-Jun Huang; Xiao-Dong Mo
Journal:  Front Oncol       Date:  2022-01-06       Impact factor: 6.244

Review 6.  Burden and Needs of Patients with Severe GvHD from the Supportive and Palliative Care Perspective-A Literature Review.

Authors:  Freya Wenzel; Anne Pralong; Udo Holtick; Christoph Scheid; Marco Herling; Steffen T Simon
Journal:  Cancers (Basel)       Date:  2021-05-30       Impact factor: 6.639

7.  Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized study.

Authors:  Ying-Jun Chang; Yu Wang; Lan-Ping Xu; Xiao-Hui Zhang; Huan Chen; Yu-Hong Chen; Feng-Rong Wang; Yu-Qian Sun; Chen-Hua Yan; Fei-Fei Tang; Xiao-Dong Mo; Yan-Rong Liu; Kai-Yan Liu; Xiao-Jun Huang
Journal:  J Hematol Oncol       Date:  2020-03-30       Impact factor: 17.388

8.  Comparable Outcomes and Health-Related Quality of Life for Severe Aplastic Anemia: Haploidentical Combined With a Single Cord Blood Unit vs Matched Related Transplants.

Authors:  Meiqing Lei; Xiaoli Li; Yanming Zhang; Qi Qu; Wenjing Jiao; Huifen Zhou; Qingyuan Wang; Huiying Qiu; Xiaowen Tang; Yue Han; Chengcheng Fu; Zhengming Jin; Suning Chen; Aining Sun; Miao Miao; Limin Liu; Depei Wu
Journal:  Front Oncol       Date:  2022-01-18       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.